Bain to buy Mubadala-backed PCI Pharma at $10b valuation: report

FILE PHOTO: The logo of Bain Capital is displayed on the screen during a news conference in Tokyo, Japan October 5, 2017. REUTERS/Kim Kyung-Hoon/File Photo

Reuters

10 May, 2025

Kohlberg Mubadala Partners Group PCI Pharma

Printed by Unregistered user on Sat, 12 Jul 2025 04:53:52 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Bain to buy Mubadala-backed PCI Pharma at $10b valuation: report

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

Bain looks to sell China data centre business of WinTriX DC likely valued at over $4b

GPs tweak China strategy to favour buyouts: Bain & Co report

Read more from Rest of Asia

Brookfield, Stonepeak and Air Liquide shortlisted for Macquarie’s $3.6b S. Korean gas firm

MUFG targets US to ramp up global securitisation business

Bain to buy Mubadala-backed PCI Pharma at $10b valuation: report

Register now to enjoy 3 free articles per month, or log in to continue reading.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

Bain looks to sell China data centre business of WinTriX DC likely valued at over $4b

GPs tweak China strategy to favour buyouts: Bain & Co report

Read more from Rest of Asia

Brookfield, Stonepeak and Air Liquide shortlisted for Macquarie’s $3.6b S. Korean gas firm

MUFG targets US to ramp up global securitisation business

Register now to enjoy 3 free articles per month,
or log in to continue reading.